In fact, patients with chronic lymphocytic leukemia, who were infused using CAR-T cells a decade ago and achieved complete cancer remission, exhibited highly activated CD4+ T cells that dominated the CAR-T cell population, corroborating a long-persisting CD4+ T cells [128]. The gene discussed is CD4; the disease is B-cell chronic lymphocytic leukemia.